Fundraising Fox

Calidi Biotherapeutics

San Diego, US · Founded 2021 · Delaware corporation

Calidi is a biotech company developing genetic medicine therapies. The page describes it as a biotech startup working in the genetic medicine field.

BiotechHealthtech

Founders & leadership

BMBoris Minev
Boris MinevinInterim Chief Medical Officer
ST
Stephen ThesinginChief Business Officer
TK
Tony KalajianInterim Chief Financial Officer
AP
Amish PatelinVice President of Technical Operations
DS
David SansinChief of Corporate Development
AC
Allan CamaisaNamed on SEC filing
HL
Heehyoung LeeNamed on SEC filing
AZ
Alfonso ZuluetaNamed on SEC filing
AF
Anthony F. SantidrianNamed on SEC filing
WP
Wendy PizarroNamed on SEC filing
SLScott Leftwich
Scott LeftwichNamed on SEC filing
JAJames A. Schoeneck
James A. SchoeneckNamed on SEC filing

Reported raises · per SEC filings

Form D private placements

$15.3M disclosed across 7 rounds · 2023–2024

▶$5.5MraisedJun 2024 · 9 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • James A. SchoeneckDirector
  • George NgDirector
  • Boris MinevExecutive Officer
  • Scott LeftwichDirector
  • Wendy PizarroExecutive Officer
  • Alan R. StewartDirector
  • Andrew JacksonExecutive Officer
  • Allan CamaisaExecutive Officer, Director
Offering amount
$5.5M
Amount sold
$5.5M
Sales commissions
$393.2K
Placement agents
LADENBURG THALMANN & CO. INC.
First sale
Jun 2024
Incorporated
Corporation, Delaware, 2021
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$32.5KraisedMar 2024 · 1 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Alan R. StewartDirector
  • George NgDirector
  • Boris MinevExecutive Officer
  • James A. SchoeneckDirector
  • Allan CamaisaExecutive Officer, Director
  • David LaPreDirector
  • Andrew JacksonExecutive Officer
  • Wendy PizarroExecutive Officer
  • Scott LeftwichDirector
Offering amount
$65K
Amount sold
$32.5K
First sale
Feb 2024
Incorporated
Corporation, Delaware, 2021
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$10KraisedMar 2024 · 1 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • David LaPreDirector
  • Wendy PizarroExecutive Officer
  • James A. SchoeneckDirector
  • Andrew JacksonExecutive Officer
  • Alan R. StewartDirector
  • George NgDirector
  • Allan CamaisaExecutive Officer, Director
  • Scott LeftwichDirector
  • Boris MinevExecutive Officer
Offering amount
$10K
Amount sold
$10K
First sale
Jan 2024
Incorporated
Corporation, Delaware, 2021
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$195KraisedMar 2024 · 1 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Alan R. StewartDirector
  • Andrew JacksonExecutive Officer
  • George NgDirector
  • David LaPreDirector
  • Boris MinevExecutive Officer
  • Allan CamaisaExecutive Officer, Director
  • Scott LeftwichDirector
  • James A. SchoeneckDirector
  • Wendy PizarroExecutive Officer
Offering amount
$341.3K
Amount sold
$195K
First sale
Nov 2023
Incorporated
Corporation, Delaware, 2021
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$3.5MraisedMar 2024 · 1 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Scott LeftwichDirector
  • Andrew JacksonExecutive Officer
  • George NgDirector
  • Boris MinevExecutive Officer
  • Wendy PizarroExecutive Officer
  • Alan R. StewartDirector
  • David LaPreDirector
  • James A. SchoeneckDirector
  • Allan CamaisaExecutive Officer, Director
Offering amount
$3.5M
Amount sold
$3.5M
First sale
Mar 2024
Incorporated
Corporation, Delaware, 2021
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$1MraisedMar 2024 · 1 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Wendy PizarroExecutive Officer
  • Boris MinevExecutive Officer
  • Allan CamaisaExecutive Officer, Director
  • Andrew JacksonExecutive Officer
  • David LaPreDirector
  • George NgDirector
  • Scott LeftwichDirector
  • James A. SchoeneckDirector
  • Alan R. StewartDirector
Offering amount
$1M
Amount sold
$1M
First sale
Jan 2024
Incorporated
Corporation, Delaware, 2021
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$5MraisedJun 2023 · 1 investors · Biotechnology
Rule 506(c)
Officers, directors & promoters on the filing
  • Allan CamaisaExecutive Officer, Director
  • Heehyoung LeeDirector
  • James SchoeneckDirector
  • Alfonso ZuluetaDirector
  • Anthony F. SantidrianExecutive Officer
  • Boris MinevExecutive Officer
  • Stephen ThesingExecutive Officer
  • Tony KalajianExecutive Officer
  • Amish PatelExecutive Officer
  • David SansExecutive Officer
  • Wendy PizarroExecutive Officer
  • Scott LeftwichDirector
  • George NgDirector
Offering amount
$25M
Amount sold
$5M
Sales commissions
$50K
Proceeds to insiders
$648K
Placement agents
Brookline Capital Markets
First sale
Jun 2023
Incorporated
Corporation, Nevada
Federal exemptions
06c
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Competitors · 4

by search overlap
Robinhood20 shared keywordsRobinhood is a financial trading platform that enables users to manage portfolios across stocks, ETFs, cryptocurrencies, options, futures, and prediction markets. The platform serves retail investors with low barriers to entry, offering portfolio management services and market insights.
Seeking Alpha16 shared keywordsSeeking Alpha is a financial research platform offering stock analysis, market news, investment ideas, and quantitative ratings across asset classes, drawing on a large community of contributing analysts. It serves individual and professional investors seeking research and data-driven insight on stocks and markets.
TradingView13 shared keywordsTradingView is a charting platform and social network used by over 100 million traders and investors worldwide to analyze and trade across global financial markets. The platform provides tools for technical analysis, market data, and community collaboration for retail and institutional traders.
StockTwits12 shared keywordsStocktwits operates an online community platform where investors and traders share ideas, analysis, and trade discussions organized around stock tickers. The page presented is its community guidelines rather than a product description.

Companies competing with Calidi Biotherapeutics for the same Google search keywords, organic and paid, via search-intersection analysis.

Frequently asked questions

What does Calidi Biotherapeutics do?
Calidi is a biotech company developing genetic medicine therapies. The page describes it as a biotech startup working in the genetic medicine field.
How much funding has Calidi Biotherapeutics raised?
Calidi Biotherapeutics has disclosed $15.3M raised across 7 rounds.
Where is Calidi Biotherapeutics headquartered?
Calidi Biotherapeutics is headquartered in San Diego, US.